We are at a critical time and supporting climate journalism is more important than ever. Science News and our parent organization, the Society for Science, need your help to strengthen ...

Meanwhile, a trial of semaglutide in people with chronic kidney disease and diabetes was halted early because it showed clear evidence of efficacy. Other studies are investigating the drug in ...